These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6090179)

  • 1. Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds.
    Isenberg KE; Cicero TJ
    Eur J Pharmacol; 1984 Aug; 103(1-2):57-63. PubMed ID: 6090179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment.
    Yoburn BC; Goodman RR; Cohen AH; Pasternak GW; Inturrisi CE
    Life Sci; 1985 Jun; 36(24):2325-32. PubMed ID: 2989632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone-induced opiate receptor supersensitivity.
    Zukin RS; Sugarman JR; Fitz-Syage ML; Gardner EL; Zukin SR; Gintzler AR
    Brain Res; 1982 Aug; 245(2):285-92. PubMed ID: 6289965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF; Nishimura S; Goodman RR; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic opioid antagonist treatment: assessment of receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Eur J Pharmacol; 1989 Nov; 170(3):193-200. PubMed ID: 2559854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of beta-funaltrexamine on radiolabeled opioid binding.
    Recht LD; Pasternak GW
    Eur J Pharmacol; 1987 Aug; 140(2):209-14. PubMed ID: 2822439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICI 154,129, a delta-opioid receptor antagonist raises seizure threshold in rats.
    Tortella FC; Robles LE; Holaday JW; Cowan A
    Eur J Pharmacol; 1984 Jan; 97(1-2):141-4. PubMed ID: 6321207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist.
    Galetta S; Hahn EF; Nishimura S; Pasternak GW
    Life Sci; 1987 Aug; 41(6):783-7. PubMed ID: 2441221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.
    Yoburn BC; Nunes FA; Adler B; Pasternak GW; Inturrisi CE
    J Pharmacol Exp Ther; 1986 Oct; 239(1):132-5. PubMed ID: 3020228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu and delta opioid receptor interactions in a rat model of drug induced seizures.
    Tortella FC; Holaday JW
    Proc West Pharmacol Soc; 1984; 27():435-7. PubMed ID: 6093137
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alpha interferon interaction with opiate receptors in the rat brain].
    Panchenko LF; Aliab'eva TN; Malinovskaia VV; Balashov AM
    Biull Eksp Biol Med; 1987 Jul; 104(7):87-9. PubMed ID: 3040148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specific binding of mu- and delta-ligands by opiate receptors in the rat brain in the presence of reaferon].
    Panchenko LF; Aliab'eva TN; Petrichenko OB; Bumialis VV; Balashov AM
    Biull Eksp Biol Med; 1988 Sep; 106(9):307-9. PubMed ID: 2844322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
    Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
    J Pharmacol Exp Ther; 1988 Nov; 247(2):405-16. PubMed ID: 2846819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
    Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic morphine upregulates a mu-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomography.
    Rothman RB; McLean S; Bykov V; Lessor RA; Jacobson AE; Rice KC; Holaday JW
    Eur J Pharmacol; 1987 Oct; 142(1):73-81. PubMed ID: 2826178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselectivity and subtype of the opiate receptor involved in stress-induced hypertension.
    Jiménez I; Iglesias T; Fuentes JA
    Eur J Pharmacol; 1990 Jun; 182(1):155-60. PubMed ID: 2169423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect ot thyroliberin on rat brain opiate receptors].
    Balashov AM; Shchurin MR
    Biull Eksp Biol Med; 1986 Aug; 102(8):174-6. PubMed ID: 3017473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.